Ramy Arnaout, M.D., Ph.D.
This page shows the publications co-authored by Ramy Arnaout and James Kirby.
The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 Testing. Clin Infect Dis. 2021 11 02; 73(9):e3042-e3046.
SARS-CoV2 Testing: The Limit of Detection Matters. bioRxiv. 2020 Jun 04.
SARS-CoV-2 Antigen Tests Predict Infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large Sample Cohort. Clin Microbiol Infect. 2022 Jul 18.
Verification of the Abbott Alinity m Resp-4-Plex assay for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus. Diagn Microbiol Infect Dis. 2022 Feb; 102(2):115575.
Nasal Swab Performance by Collection Timing, Procedure, and Method of Transport for Patients with SARS-CoV-2. J Clin Microbiol. 2021 08 18; 59(9):e0056921.
Saliva is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2. Microbiol Spectr. 2021 09 03; 9(1):e0016221.
Open Development and Clinical Validation of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck. J Clin Microbiol. 2020 07 23; 58(8).
Nasal-Swab Testing Misses Patients with Low SARS-CoV-2 Viral Loads. medRxiv. 2020 Jun 14.
Utility of microbiological testing of thoracic lymph nodes sampled by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in patients with mediastinal lymphadenopathy. Diagn Microbiol Infect Dis. 2016 Feb; 84(2):170-4.
Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron and Delta Variants of Concern Using Live-Virus Culture. J Clin Microbiol. 2022 05 18; 60(5):e0014022.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.